From GlobeNewswire: 2025-06-13 09:00:00

RAPT Therapeutics, Inc. will undergo a 1-for-8 reverse stock split effective June 16, 2025. Following the split, their stock will trade on the Nasdaq Global Market under the symbol “RAPT” with a new CUSIP number. The split will not change the par value per share and will affect all stockholders uniformly, reducing the number of outstanding shares from 132.3 million to 16.5 million. RAPT is a biopharmaceutical company focused on developing therapies for inflammatory and immunological diseases. Forward-looking statements caution potential risks and uncertainties associated with the reverse stock split.



Read more at GlobeNewswire: RAPT Therapeutics Announces Effective Date for 1-for-8